20161216_135258.jpg

Dr Sulbha Pai, Pharmacist

  • Serving the Boca Raton Community
  • 15 Years of Experience
  • Expertise in Diabetic Care and Education

Joint CDC & FDA Statement on Johnson & Johnson COVID-19 Vaccine

The following statement is attributed to Dr. Anne Schuchat, Principal Deputy Director of the CDC and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.

As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen ) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination. Treatment of this specific type of blood clot is different from the treatment that might typically be administered. Usually, an anticoagulant drug called heparin is used to treat blood clots. In this setting, administration of heparin may be dangerous, and alternative treatments need to be given.

CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases. Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution. This is important, in part, to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot.

Right now, these adverse events appear to be extremely rare. COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously. People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider. Health care providers are asked to report adverse events to the Vaccine Adverse Event Reporting System at https://vaers.hhs.gov/reportevent.html. CDC and FDA will provide additional information and answer questions later today at a media briefing. A recording of that media call will be available on the FDA’s YouTube channel.

We Care For Your And About You. We don't cost more, Just Care More!

Here at KPB Pharmacy, your family's health is our top priority and take the time to answer any questions. We offer traditional prescription filling, compounding, immunizations, long term care and much more.

Compounding (3).jpg

Compounding

  • We offer a wide range of compounding services, including veterinary and hormone replacement therapy.

Learn More

Immunizations (1).jpg

Immunizations

    • We offer a variety of vaccines to keep you and your family healthy. Contact us to learn more about our immunizations.

  • Learn more
Travel Vaccinations

Travel Vaccinations

  • Planning on traveling to out of the o? Before jetting off, make sure you are up to date on routine vaccinations.

Learn More

Long Term Care (1).jpg

Long Term Care

We provide medications and consultant pharmacy services to long-term care facilities such as nursing homes.

Learn More

What Our Patients Love About Our Pharmacy

The people are extremely helpful. Pricing is fantastic. Do recommend highly.
Robert A.
Great pharmacy. Lance is truly concerned about and available to all his customers. Never a long wait either.
Prince J.
Staffing is real nice and hardly any wait time for your medications to be filled!!
Sherrie W.

Subscribe to our newsletter 

Stay up to date with our pharmacy with exclusive content.